Eventide Asset Management - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2019$13,398,000
-50.6%
966,000
-31.6%
0.41%
-56.4%
Q1 2019$27,125,000
+34.6%
1,412,0000.0%0.93%
+4.6%
Q4 2018$20,149,000
+38.4%
1,412,000
+102.0%
0.89%
+66.7%
Q3 2018$14,560,000
-12.0%
699,0000.0%0.54%
-22.1%
Q2 2018$16,545,000699,0000.69%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
J.P. Turner & Co Capital Mnagement, LLC 235,575$900,0000.83%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,505,972$9,598,0000.31%
Bellevue Asset Management AG 400,000$1,532,0000.21%
Perceptive Advisors 600,000$2,625,0000.20%
WCM INVESTMENT MANAGEMENT, LLC 1,888,913$7,234,0000.15%
SPHERA FUNDS MANAGEMENT LTD. 300,000$1,149,0000.12%
Nair Vinay 37,721$144,0000.10%
J.P. Turner & Co Capital Mnagement, LLC 107,700$101,0000.09%
Iguana Healthcare Management, LLC 50,000$192,0000.08%
Tekla Capital Management LLC 500,000$1,915,0000.08%
View complete list of IMMUNOMEDICS INC shareholders